These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 9210669

  • 21. In-vitro activity of trovafloxacin against sensitive and resistant aerobic bacteria using the standard microdilution broth method and Etest.
    Dembry LM, Farrel PA, Orcutt DR, Gerrity LA, Andriole VT.
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():35-42. PubMed ID: 9222068
    [Abstract] [Full Text] [Related]

  • 22. In vitro activity of azithromycin in combination with amikacin, ceftazidime, ciprofloxacin or imipenem against clinical isolates of Acinobacter baumannii.
    Fernández-Cuenca F, Martínez-Martínez L, Pascual A, Perea EJ.
    Chemotherapy; 2003 May; 49(1-2):24-6. PubMed ID: 12714805
    [Abstract] [Full Text] [Related]

  • 23. Susceptibility of Xanthomonas maltophilia and amikacin-resistant gram-negative bacteria to newer antimicrobials.
    Matsuyama JR, Beail B, Wallis C, Zeleznik D, Tartaglione T.
    Clin Pharm; 1991 Jul; 10(7):544-8. PubMed ID: 1860303
    [Abstract] [Full Text] [Related]

  • 24. Synergistic activity of trovafloxacin with other agents against gram-positive and -negative organisms.
    Visalli MA, Bajaksouzian S, Jacobs MR, Appelbaum PC.
    Diagn Microbiol Infect Dis; 1998 Jan; 30(1):61-4. PubMed ID: 9488833
    [Abstract] [Full Text] [Related]

  • 25. Susceptibilities of 123 Xanthomonas maltophilia strains to clinafloxacin, PD 131628, PD 138312, PD 140248, ciprofloxacin, and ofloxacin.
    Pankuch GA, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 1994 Feb; 38(2):369-70. PubMed ID: 8192468
    [Abstract] [Full Text] [Related]

  • 26. Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin.
    Bauernfeind A.
    J Antimicrob Chemother; 1997 Nov; 40(5):639-51. PubMed ID: 9421311
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Comparison of in vitro activity of trovafloxacin against gram-positive and gram-negative organisms with quinolones and beta-lactam antimicrobial agents.
    Dembry LM, Roberts JC, Schock KD, Marino SP, Farrel PA, Andriole VT.
    Diagn Microbiol Infect Dis; 1998 May; 31(1):301-11. PubMed ID: 9597391
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Antimicrobial susceptibility of flavobacteria as determined by agar dilution and disk diffusion methods.
    Chang JC, Hsueh PR, Wu JJ, Ho SW, Hsieh WC, Luh KT.
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1301-6. PubMed ID: 9174188
    [Abstract] [Full Text] [Related]

  • 36. [The activity of four fluoroquinolones against strains of Pseudomonas aeruginosa with a different sensitivity pattern to ceftazidime and imipenem].
    Pascual A A, Joyanes P, Martínez-Martínez L, del Carmen Conejo M, Hernández G, Chaves J, Perea EJ.
    Enferm Infecc Microbiol Clin; 2001 Nov; 19(9):432-4. PubMed ID: 11709121
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. In-vitro susceptibilities of Pseudomonas aeruginosa and Pseudomonas spp. to the new fluoroquinolones clinafloxacin and PD 131628 and nine other antimicrobial agents.
    Ford AS, Baltch AL, Smith RP, Ritz W.
    J Antimicrob Chemother; 1993 Apr; 31(4):523-32. PubMed ID: 8390434
    [Abstract] [Full Text] [Related]

  • 39. [Evaluation of antibacterial activities of various antibiotics against glucose non-fermentative gram-negative rods other than Pseudomonas aeruginosa].
    Kouda M, Fukuhara J, Takeuchi M, Ohgawara M, Matsuzaki H, Tohi H, Furuhata N, Maruyama M, Sasaki K, Sawabe E, Ikeda A, Suzuki T, Satoh H, Takahashi I, Kimura F, Nomura H, Ono E.
    Jpn J Antibiot; 1998 Jul; 51(7):475-87. PubMed ID: 9755431
    [Abstract] [Full Text] [Related]

  • 40. Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methods.
    Bajaksouzian S, Visalli MA, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 1996 Sep; 40(9):1973-6. PubMed ID: 8878565
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.